NOURIANZ
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 21 Jan 2026)
What this means for you
Registered since 04 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87086056
- Registration number
- 5978485
- Mark type
- Stylized text
- Filed
- 28 Jun 2016
- Published for opposition
- 15 Nov 2016
- Registered
- 04 Feb 2020
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of the central nervous system disorders; pharmaceutical preparations for the treatment of Parkinson's disease [ , Alzheimer's disease, depression, anxiety, ] *and* movement disorders [ , memory impairment, brain disorder and brain dysfunction ]
Owner
- KYOWA KIRIN CO., LTD., TOKYO, JP
- KYOWA KIRIN CO., LTD., TOKYO, JP
- Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku,Tokyo, JP
- Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku,Tokyo, JP
Prosecution history
- 21 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 04 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Dec 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Dec 2019 — USE AMENDMENT FILED
- 02 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
- 04 Sept 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2019 — SOU EXTENSION 5 GRANTED
- 03 Jul 2019 — SOU EXTENSION 5 FILED